Koninklijke Philips NV
PHG25.020USD
-0.240-0.95%
Close 04/29, 16:00（ET）Quotes delayed by 15 min
23.14BMarket Cap
LossP/E TTM
More Details of Koninklijke Philips NV Company
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Company Info
Company codePHG
Company nameKoninklijke Philips NV
IPO dateSep 18, 2009
Founded at2000
CEOMr. Roy Jakobs
Number of employees67823
Security typeOrdinary Share
Fiscal year-endSep 18
AddressHigh Tech Campus 5
CityEINDHOVEN
Stock exchangeThe Stock Exchange of Thailand
CountryNetherlands
Postal code5656 AE
Phone31205977777
Websitehttps://www.philips.com/
Company codePHG
IPO dateSep 18, 2009
Founded at2000
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Steve C. De Baca
Mr. Steve C. De Baca
Executive Vice President, Chief Patient Safety and Quality Officer
Executive Vice President, Chief Patient Safety and Quality Officer
--
--
Mr. Benoit Ribadeau-Dumas
Mr. Benoit Ribadeau-Dumas
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. David E. I. Pyott, CBE
Mr. David E. I. Pyott, CBE
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Jie Xue
Ms. Jie Xue
Executive Vice President, Chief Business Leader Precision Diagnosis
Executive Vice President, Chief Business Leader Precision Diagnosis
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Ms. Julia Strandberg
Ms. Julia Strandberg
Executive Vice President, Chief Business Leader Connected Care
Executive Vice President, Chief Business Leader Connected Care
--
--
Ms. Ozlem Duzen Fidanci
Ms. Ozlem Duzen Fidanci
Executive Vice President, Chief of International Region and Leader Growth Region
Executive Vice President, Chief of International Region and Leader Growth Region
--
--
Ms. Liu Ling
Ms. Liu Ling
Executive Vice President, Chief Region Leader of Philips Greater China
Executive Vice President, Chief Region Leader of Philips Greater China
--
--
Mr. A. Marc Harrison
Mr. A. Marc Harrison
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Steve C. De Baca
Mr. Steve C. De Baca
Executive Vice President, Chief Patient Safety and Quality Officer
Executive Vice President, Chief Patient Safety and Quality Officer
--
--
Mr. Benoit Ribadeau-Dumas
Mr. Benoit Ribadeau-Dumas
Member of the Supervisory Board
Member of the Supervisory Board
--
--
Mr. David E. I. Pyott, CBE
Mr. David E. I. Pyott, CBE
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Jie Xue
Ms. Jie Xue
Executive Vice President, Chief Business Leader Precision Diagnosis
Executive Vice President, Chief Business Leader Precision Diagnosis
--
--
Ms. M. Elizabeth (Liz) Doherty
Ms. M. Elizabeth (Liz) Doherty
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert Van Meurs
Mr. Bert Van Meurs
Executive Vice President, Chief Business Leader - Image Guided Therapy
Executive Vice President, Chief Business Leader - Image Guided Therapy
--
--
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
United States
7.82B
40.10%
Other Countries
6.05B
31.05%
Netherlands
2.71B
13.91%
China
1.25B
6.40%
Japan
958.28M
4.92%
Germany
706.27M
3.62%
By Business
By Region
No Data
Shareholder
Update time: Fri, Mar 28
Update time: Fri, Mar 28
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Mondrian Investment Partners Ltd.
0.77%
Fiduciary Management, Inc.
0.67%
Fidelity Management & Research Company LLC
0.59%
Dimensional Fund Advisors, L.P.
0.46%
BlackRock Investment Management, LLC
0.26%
Other
97.25%
Shareholder Statistics
Shareholder
Proportion
Mondrian Investment Partners Ltd.
0.77%
Fiduciary Management, Inc.
0.67%
Fidelity Management & Research Company LLC
0.59%
Dimensional Fund Advisors, L.P.
0.46%
BlackRock Investment Management, LLC
0.26%
Other
97.25%
Type
Shareholder
Proportion
Investment Advisor
4.31%
Investment Advisor/Hedge Fund
1.47%
Research Firm
0.28%
Hedge Fund
0.17%
Bank and Trust
0.07%
Family Office
0.05%
Family Office
0.04%
Family Office
0.04%
Other
93.57%
Institutional Shareholding
Update time: Mon, Jan 20
Update time: Mon, Jan 20
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
559
59.05M
6.38%
-13.12M
2024Q4
583
60.06M
6.49%
-29.02M
2024Q3
590
63.64M
6.83%
-28.01M
2024Q2
594
65.28M
6.99%
-29.22M
2024Q1
610
73.19M
7.82%
-21.31M
2023Q4
642
73.00M
7.79%
-18.85M
2023Q3
666
68.56M
7.24%
-21.16M
2023Q2
676
66.71M
7.01%
-36.31M
2023Q1
689
68.47M
7.19%
-38.94M
2022Q4
703
88.43M
9.29%
-24.60M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Mondrian Investment Partners Ltd.
7.14M
0.77%
-759.34K
-9.62%
Dec 31, 2024
Fiduciary Management, Inc.
6.18M
0.67%
-290.89K
-4.50%
Dec 31, 2024
Fidelity Management & Research Company LLC
5.48M
0.59%
-35.58K
-0.65%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
4.29M
0.46%
+85.99K
+2.05%
Dec 31, 2024
BlackRock Investment Management, LLC
2.38M
0.26%
-611.98K
-20.43%
Dec 31, 2024
Connor, Clark & Lunn Investment Management Ltd.
2.22M
0.24%
+1.04M
+87.71%
Dec 31, 2024
Parametric Portfolio Associates LLC
1.74M
0.19%
-71.06K
-3.91%
Dec 31, 2024
Causeway Capital Management LLC
1.57M
0.17%
+303.43K
+24.02%
Dec 31, 2024
Envestnet Asset Management, Inc.
1.37M
0.15%
-44.99K
-3.18%
Dec 31, 2024
Northern Trust Global Investments
1.36M
0.15%
+259.57K
+23.61%
Dec 31, 2024
View more
Related ETFs
Update time: Sun, Apr 6
Update time: Sun, Apr 6
Name
Proportion
Langar Global HealthTech ETF
5.58%
Brandes International ETF
1.64%
Brandes US Small-Mid Cap Value ETF
1.32%
ActivePassive International Equity ETF
0.34%
DFA Dimensional Intl Sustainability Core 1 ETF
0.2%
Avantis International Large Cap Value ETF
0.2%
Avantis Responsible International Equity ETF
0.15%
SPDR S&P Kensho New Economies Composite ETF
0.14%
Avantis International Equity ETF
0.11%
DFA Dimensional International Core Equity 2 ETF
0.1%
View more
Langar Global HealthTech ETF
Proportion5.58%
Brandes International ETF
Proportion1.64%
Brandes US Small-Mid Cap Value ETF
Proportion1.32%
ActivePassive International Equity ETF
Proportion0.34%
DFA Dimensional Intl Sustainability Core 1 ETF
Proportion0.2%
Avantis International Large Cap Value ETF
Proportion0.2%
Avantis Responsible International Equity ETF
Proportion0.15%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.14%
Avantis International Equity ETF
Proportion0.11%
DFA Dimensional International Core Equity 2 ETF
Proportion0.1%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data